Giuseppe CuriglianoDr. Giuseppe Curigliano, MD PhD, is a Full Professor of Medical Oncology at the University of Milan and the Chief of the Clinical Division of Early Drug Development at European Institute of Oncology, Milan, Italy. Dr. Curigliano is an expert in the feld of advanced drug development in solid tumors, with specific interest in breast cancer. He contributed to the development of many anticancer treatments currently available as standard of care in the treatment of multiple solid tumors. Dr Curigliano in 2022 was identified as Clarivate™ world’s most influential researchers. Dr Curigliano has contributed to over 670 peer-reviewed publications. Read More Read Less